Загрузка...
995. A quality improvement initiative to increase penicillin allergy clarification and decrease aztreonam usage
BACKGROUND: Penicillin (PCN) allergy is a serious adverse reaction that prevents the use of first-line therapy. 10% of the population reports a PCN allergy; however, less than 1% is truly allergic. Elimination of false allergies significantly impacts patient’s lives and decreases antimicrobial resis...
Сохранить в:
| Опубликовано в: : | Open Forum Infect Dis |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6811020/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.859 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|